New York 2025-2026 Regular Session

New York Assembly Bill A08820

Introduced
6/9/25  
Refer
6/9/25  

Caption

Authorizes the office of cannabis management and cannabis control board to establish a track and trace program; requires certain tracking requirements on cannabis sold within the state.

Summary

This bill amends the state finance law governing the New York State Cannabis Revenue Fund to clarify and expand the types of costs that may be paid from the fund. Specifically, it allows the Office of Cannabis Management and the Cannabis Control Board to use fund money for implementing, administering, and enforcing the Marihuana Regulation and Taxation Act, including the cost of a track-and-trace program with a unique package identifier. The bill also defines key terms for that tracking system, including what counts as a “package” and “line items” for purposes of shipping manifests. In practical terms, the bill is aimed at strengthening cannabis product tracking and regulatory oversight in New York’s legal cannabis market. It ties the revenue fund to compliance infrastructure, making it easier for the state to finance systems used to monitor cannabis products through the supply chain and distinguish case-level identifiers from unit-level identifiers. The bill takes effect immediately.

Impact

The bill would amend section 99-ii of the state finance law, broadening the permissible uses of the New York State Cannabis Revenue Fund to include track-and-trace implementation costs and related enforcement expenses. It directly affects the Office of Cannabis Management, the Cannabis Control Board, and cannabis licensees and distributors subject to state tracking requirements, while supporting state enforcement of cannabis regulation and taxation laws.

Sentiment

The available record suggests generally supportive or noncontroversial treatment of the bill, as reflected by its advancement through committee and amendment process without any recorded votes or transcript opposition in the provided materials. The bill appears to be a technical but policy-significant measure focused on regulatory administration rather than a broader substantive change to cannabis legalization.

Contention

The main policy issue embedded in the bill is the scope and design of the track-and-trace system, including how broadly the state may define a “package” and whether identifiers apply at the case level rather than to individual product units. While no explicit opposition is shown in the provided record, these definitions could matter to cannabis businesses concerned about compliance costs, reporting burdens, and the operational details of product tracking. The bill also reflects a funding question: whether cannabis revenue should be used for administrative and enforcement infrastructure tied to market oversight.

Companion Bills

NY S08264

Same As Authorizes funds in the New York state cannabis revenue fund to be used for reasonable costs of implementing track and tracing of product programs.

Previously Filed As

NY S08264

Authorizes funds in the New York state cannabis revenue fund to be used for reasonable costs of implementing track and tracing of product programs.

NY AB2250

Cannabis: cannabinoids.

NY LD1847

An Act to Institute Testing and Tracking of Medical Use Cannabis and Cannabis Products Similar to Adult Use Cannabis and Cannabis Products, Dedicate a Portion of the Adult Use Cannabis Sales and Excise Tax to Medical Use Cannabis Programs and Create a Study Group

NY AB8

Cannabis: cannabinoids: industrial hemp.

NY SB1008

Alcohol and Cannabis - Cannabinoid Beverages Off-Premises Sales Permit - Establishment

NY HB51

Relative to hemp-derived cannabinoids and the definition of cannabis in therapeutic cannabis.

NY A4652

Codifies certain cannabis packaging requirements; establishes offense for minor gaining access to improperly stored cannabis products.

NY HF2426

Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.

NY SF2165

Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision

NY SB49

Establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for permits and for dispensing cannabis to patients and caregivers; and making repeals.

Similar Bills

No similar bills found.